Skip to main content
Back
OSCR logo

Oscar Health, Inc.

Data quality: 100%
OSCR
NYSE Healthcare Medical - Healthcare Plans
$12.21
▲ $0.18 (1.50%)
Mkt Cap: 3.17B
Day Range
$11.78 $12.57
52-Week Range
$11.20 $23.80
Volume
5,649,376
50D / 200D Avg
$14.26 / $16.25
Prev Close
$12.03

Quick Summary

Price History

Financial Trends

Peer Comparison

vs Healthcare sector median (631 peers)

Metric Stock Sector Median
P/E -7.1 0.2
P/B 3.2 3.0
ROE % -44.5 3.6
Net Margin % -3.8 3.8
Rev Growth 5Y % 57.1 10.0
D/E 0.4 0.2

Analyst Price Target

Hold
$16.40 +34.3%
Low: $14.00 High: $18.00
Forward P/E
32.29
Forward EPS
$0.38
EPS Growth (est.)
+0.0%
Est. Revenue
18.72B

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2028 $1.88
$1.22 – $2.31
 21.56B 3
FY2027 $1.11
-$0.11 – $1.86
 19.74B 6
FY2026 $0.38
-$1.19 – $1.40
 18.72B 5

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-10 -$0.92 -$1.24 -34.6%
2025-11-06 -$0.55 -$0.53 +3.6%
2025-08-06 -$0.90 -$0.89 +1.1%
2025-05-07 $0.83 $0.92 +10.8%
2025-02-04 -$0.55 -$0.62 -12.7%
2024-11-07 -$0.20 -$0.22 -10.0%
2024-08-07 $0.16 $0.20 +25.0%
2024-05-07 $0.27 $0.62 +129.6%

Dividend History

Yield

0.00%

Payout Ratio

0.00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

Key Takeaways

Revenue grew 57.10% annually over 5 years — strong growth
Earnings declined -1842.49% over the past year
Debt/Equity of 0.44 — conservative balance sheet
Generating 1.06B in free cash flow
PEG of 0.01 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 29.60%

Growth

Revenue Growth (5Y)
57.10%
Revenue (1Y)27.50%
Earnings (1Y)-1842.49%
FCF Growth (3Y)N/A

Quality

Return on Equity
-44.51%
ROIC-21.12%
Net Margin-3.79%
Op. Margin-3.39%

Safety

Debt / Equity
0.44
Current Ratio0.95
Interest Coverage-22.52

Valuation

P/E Ratio
-7.14
Forward P/E32.29
P/B Ratio3.24
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 27.50% Revenue Growth (3Y) 41.27%
Earnings Growth (1Y) -1842.49% Earnings Growth (3Y) N/A
Revenue Growth (5Y) 57.10% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 11.70B Net Income (TTM) -443.15M
ROE -44.51% ROA -7.01%
Gross Margin 14.38% Operating Margin -3.39%
Net Margin -3.79% Free Cash Flow (TTM) 1.06B
ROIC -21.12% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.44 Current Ratio 0.95
Interest Coverage -22.52
Dividends
Dividend Yield 0.00% Payout Ratio 0.00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -7.14 Forward P/E 32.29
P/B Ratio 3.24 P/S Ratio 0.27
PEG Ratio 0.01 Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 0.17 Fwd Earnings Yield 3.10%
FCF Yield 33.44%
Market Cap 3.17B Enterprise Value 821.67M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 11.70B 9.18B 5.86B 4.13B 1.92B
Net Income -443.15M 25.43M -270.73M -606.28M -572.61M
EPS (Diluted) -1.69 0.10 -1.22 -2.85 -3.19
Gross Profit 1.68B 1.84B 1.22B 4.13B 1.92B
Operating Income -396.36M 57.27M -235.62M -610.08M -570.58M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 6.33B 4.84B 3.60B 4.53B 3.32B
Total Liabilities 5.34B 3.82B 2.80B 3.63B 1.93B
Shareholders' Equity 977.65M 1.01B 803.97M 890.38M 1.39B
Total Debt 430.10M 299.56M 298.78M 298.00M 0.0
Cash & Equivalents 2.77B 1.53B 1.87B 1.56B 1.10B
Current Assets 4.61B 2.85B 2.07B 4.12B 2.77B
Current Liabilities 4.86B 3.17B -175.28M 3.26B 1.62B

Strategy Scores

This stock passed the criteria for 2 strategies

Score = fit strength (0–100)
Rank = position among all matches
Growth Price/Sales Ratio Focus (Ken Fisher)
#105 of 619
66
Custom Full Throttle
#106 of 148
33

Recent Activity

Entered Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026
Entered Full Throttle
Mar 24, 2026